Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Pedigree Analysis01:35

Pedigree Analysis

90.5K
Overview
90.5K
Pedigree Analysis01:35

Pedigree Analysis

19.0K
19.0K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

94
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
94
Genetic Lingo01:11

Genetic Lingo

117.0K
Overview
117.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifestyle among urology trainees and young urologist in the context of burn-out syndrome.

Actas urologicas espanolas·2019
Same author

Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review.

Thrombosis research·2018
Same author

von Willebrand disease Outreach into Integrated Care Education (VOICE): a call to action.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Hepatitis C in haemophilia: time for treatment for all.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same journal

Prophylactic Factor Replacement Versus on-Demand Factor Replacement Following Primary Total Knee Arthroplasty in Patients With Hemophilia: A Retrospective Study With an Average 10-Year Follow-up.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Accuracy of Factor VIII Assays for Measuring Damoctocog Alfa Pegol: A Comparative Analysis.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Real-World Assessment of rVIII-SingleChain for Prophylactic Treatment in People With Severe Hemophilia A in High-Resource Settings.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Platelet Hyperreactivity May Contribute to Thrombotic Complications in Afibrinogenemia: A Case-Based Observation.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Predictors and Clinical Impact of Time to Diagnosis in Acquired Haemophilia A: An 11-Year Retrospective Cohort Study.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND-ed.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.7K

Genetic analysis of bleeding disorders.

E Edison1, B A Konkle2, A C Goodeve3,4

  • 1Department of Haematology, Christian Medical College, Vellore, India.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|July 14, 2016
PubMed
Summary
This summary is machine-generated.

Molecular genetic analysis for inherited bleeding disorders has advanced significantly. Two distinct methods, conformation-sensitive gel electrophoresis and molecular inversion probes, are detailed for variant detection and pathogenicity assessment.

Keywords:
F8 inversionbleeding disorderconformation-sensitive gel electrophoresisdosage analysisgenetic analysisnext-generation sequencingpathogenicity prediction

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.2K

Related Experiment Videos

Last Updated: Mar 18, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.7K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.2K

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Molecular genetic analysis of inherited bleeding disorders has evolved over 30 years.
  • Technological advancements have progressed from linked markers to next-generation sequencing.
  • Current methods offer improved efficiency and comprehensive variant detection.

Purpose of the Study:

  • To describe two distinct molecular genetic analysis approaches for inherited bleeding disorders.
  • To highlight methods for identifying and confirming genetic variants.
  • To outline a systematic approach for assessing variant pathogenicity.

Main Methods:

  • Conformation-sensitive gel electrophoresis (CSGE) with Sanger sequencing confirmation (Christian Medical Centre, India).
  • Molecular inversion probes (MIP) for comprehensive exon and splice site analysis, including F8 intron 1 and 22 inversions (MyLifeOurFuture US project).
  • Utilizing population and locus-specific databases for variant frequency and pathogenicity assessment.

Main Results:

  • CSGE identifies candidate mutations for Sanger sequencing confirmation.
  • MIP enables simultaneous screening of all F8 and F9 variants in multiple samples.
  • Systematic analysis of evidence, including in silico tools, aids in reproducible pathogenicity scoring.

Conclusions:

  • Diverse molecular techniques are employed globally for diagnosing inherited bleeding disorders.
  • Standardized methods for variant pathogenicity assessment are crucial for accurate diagnosis.
  • Continued technological innovation drives progress in genetic diagnostics for bleeding disorders.